Search

Yan Guo Phones & Addresses

  • 312B Soundview Ln, College Point, NY 11356
  • Flushing, NY
  • Jersey City, NJ

Professional Records

Lawyers & Attorneys

Yan Guo Photo 1

Yan Guo - Lawyer

View page
Address:
Troutman Sanders LLP
(216) 133-8975 (Office)
Licenses:
New York - Currently registered 2010
Education:
University of California Berkeley School of Law
Yan Guo Photo 2

Yan Guo - Lawyer

View page
Office:
Fredrikson & Byron, P.A.
ISLN:
1000444902
Admitted:
2009
University:
Dongbei University of Finance and Economics, B.A., 1998; Shanghai Institute Foreign Trad, LL.M., 2002
Law School:
University of California - Berkeley, LL.M., 2009

Medicine Doctors

Yan Guo Photo 3

Yan Guo

View page
Specialties:
Ophthalmology/pediatrics
Work:
Marshfield ClinicMarshfield Clinic Marshfield Center
1000 N Oak Ave, Marshfield, WI 54449
(715) 387-5511 (phone), (715) 387-5754 (fax)
Languages:
Chinese
English
French
Spanish
Description:
Dr. Guo works in Marshfield, WI and specializes in Ophthalmology/pediatrics. Dr. Guo is affiliated with Ministry Saint Michaels Hospital and Ministry St Josephs Hospital.

Business Records

Name / Title
Company / Classification
Phones & Addresses
Yan Ling Guo
Incorporator
DRAGON GARDENS OF WV CORP
Retail Trade · Food and Beverage Stores · Specialty Food Stores
1453 Maccorkle Ave, Saint Albans, WV 25177
C/O 185 Canal St #404, New York, NY 10013
Yan Qing Guo
CHINA CITY BUFFET CORP
Yan Qin Guo
C G Y INC
39-01 Main St, Flushing, NY 11354
142-05 Roosevelt Ave 720, Flushing, NY 11354
Yan Yun Guo
SUPER BUFFET, INC
566 Main St, New Rochelle, NY 10801
543 Main St / #712, New Rochelle, NY 10801
Yan Bin Guo
President
China Education Technology, Inc

Publications

Isbn (Books And Publications)

Nonlinear Wave Equations: A Conference in Honor of Walter A. Strauss on the Occasion of His Sixtieth Birthday, May 2-3, 1998, Brown University

View page
Author

Yan Guo

ISBN #

0821820710

Us Patents

Inhibitors Of The Renal Outer Medullary Potassium Channel

View page
US Patent:
20170275302, Sep 28, 2017
Filed:
Oct 9, 2015
Appl. No.:
15/505266
Inventors:
Alexander PASTERNAK - Kenilworth NJ, US
Barbara PIO - Kenilworth NJ, US
Harry R. CHOBANIAN - Kenilworth NJ, US
Zhi-Cai SHI - Kenilworth NJ, US
Shuzhi DONG - Kenilworth NJ, US
Yan GUO - Kenilworth NJ, US
Shawn P. WALSH - Kenilworth NJ, US
Zhiqiang GUO - Rahway NJ, US
Ronald D. FERGUSON - Rahway NJ, US
Brian CATO - Secaucus NJ, US
- Rahway NJ, US
International Classification:
C07D 519/00
A61K 31/4985
C07D 471/10
A61K 31/435
C07D 498/10
A61K 31/519
A61K 31/437
A61K 31/4365
A61K 31/4375
A61K 31/4355
A61K 45/06
A61K 31/5025
Abstract:
The present invention provides compounds of Formula (I) and the pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and chronic kidney disease and conditions associated with excessive salt and water retention.

Antidiabetic Bicyclic Compounds

View page
US Patent:
20170217918, Aug 3, 2017
Filed:
Aug 6, 2015
Appl. No.:
15/328735
Inventors:
Helen CHEN - Rahway NJ, US
Steven L. COLLETTI - Kenilworth NJ, US
Duane MONG - Kenilworth NJ, US
Yan GUO - Kenilworth NJ, US
Michael MILLER - Kenilworth NJ, US
Anilkumar NAIR - Kenilworth NJ, US
Christopher W. PLUMMER - Kenilworth NJ, US
Dong XIAO - Kenilworth NJ, US
De-Yi YANG - Kenilworth NJ, US
- Rahway NJ, US
International Classification:
C07D 311/60
C07D 405/14
C07D 471/08
C07D 487/08
C07D 487/04
C07D 491/107
C07D 413/12
C07D 491/08
C07D 405/10
C07D 491/048
Abstract:
Novel compounds of the structural formula (I), and the pharmaceutically acceptable salts thereof are agonists of G-protein coupled receptor 40 (GPR40) and may be useful in the treatment, prevention and suppression of diseases mediated by the G-protein-coupled receptor 40. The compounds of the present invention may be useful in the treatment of Type 2 diabetes mellitus, and of conditions that are often associated with this disease, including obesity and lipid disorders, such as mixed or diabetic dyslipidemia, hyperlipidemia, hypercholesterolemia, and hypertriglyceridemia.

Antidiabetic Compounds

View page
US Patent:
20160332968, Nov 17, 2016
Filed:
Feb 3, 2015
Appl. No.:
15/110894
Inventors:
Harry CHOBANIAN - Kenilworth NJ, US
Duane DEMONG - Kenilworth NJ, US
Yan Guo - Kenilworth NJ, US
Zhiyong Hu - Kenilworth NJ, US
Barbara PIO - Kenilworth NJ, US
Christopher PLUMMER - Kenilworth NJ, US
Dong XIAO - Kenilworth NJ, US
Cangming YANG - Kenilworth NJ, US
Rui ZHANG - Kenilworth NJ, US
- Rahway NJ, US
- Kenilworth NJ, US
International Classification:
C07D 211/42
C07D 211/22
C07D 205/04
C07D 209/54
C07D 209/52
C07D 207/12
C07D 205/12
C07C 217/52
C07D 401/04
C07D 265/30
C07C 59/72
C07D 213/64
C07D 213/69
C07D 239/52
C07D 231/20
C07D 307/88
C07D 491/056
C07D 307/86
C07D 213/30
C07D 213/647
C07D 207/08
Abstract:
Novel compounds of the structural formula (I), and the pharmaceutically acceptable salts thereof, are agonists of G-protein coupled receptor 40 (GPR40) and may be useful in the treatment, prevention and suppression of diseases mediated by the G-protein-coupled receptor 40. The compounds of the present invention may be useful in the treatment of Type 2 diabetes mellitus, and of conditions that are often associated with this disease, including obesity and lipid disorders, such as mixed or diabetic dyslipidemia, hyperlipidemia, hypercholesterolemia, and hypertriglyceridemia.

Inhibitors Of The Renal Outer Medullary Potassim Channel

View page
US Patent:
20160304515, Oct 20, 2016
Filed:
Dec 16, 2014
Appl. No.:
15/101467
Inventors:
Harry CHOBANIAN - Kenilworth NJ, US
Barbara PIO - Kenilworth NJ, US
Yan GUO - Kenilworth NJ, US
Shuzhi DONG - Kenilworth NJ, US
Shawn P. WALSH - Kenilworth NJ, US
Jinlong JIANG - Kenilworth NJ, US
Dooseop KIM - Seoul, KR
- Rahway NJ, US
International Classification:
C07D 471/04
A61K 45/06
A61K 31/55
C07D 487/04
A61K 31/4985
C07D 498/04
A61K 31/519
A61K 31/437
Abstract:
The present invention provides compounds of Formula (I) (Formula (I)) including pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and chronic kidney disease and conditions associated with excessive salt and water retention.
Yan Ling Guo from Flushing, NY, age ~53 Get Report